"
Team:Paris Bettencourt/Project/Overview
From 2013.igem.org
Ewintermute (Talk | contribs) |
Ewintermute (Talk | contribs) |
||
| Line 85: | Line 85: | ||
<center><img src="https://static.igem.org/mediawiki/2013/1/11/PB_TargetIcon.gif" style="height:50px;margin-bottom:5px;"/></center> | <center><img src="https://static.igem.org/mediawiki/2013/1/11/PB_TargetIcon.gif" style="height:50px;margin-bottom:5px;"/></center> | ||
</a> | </a> | ||
| - | <p> | + | <p> |
| + | |||
| + | test | ||
| + | |||
</p> | </p> | ||
</div> | </div> | ||
| Line 94: | Line 97: | ||
</a> | </a> | ||
<p> | <p> | ||
| - | + | ||
| + | An effective TB therapy must reach mycobacteria inside lung macrophages. In this system, <i>E. coli</i> express lysteriolysin O (LLO) to enter the macrophage cytosol and Trehalose Dimycolate Hydrolase (TDMH) to degrade the pathogen's membrane. | ||
| + | |||
</p> | </p> | ||
</div> | </div> | ||
Revision as of 20:36, 3 October 2013
<body>
To defeat tuberculosis, we need new biotechnology. Our work will add 4 new tools to the anti-TB medical armamentarium. Detect - A CRISPR-based biosensor delivered by phage and sequence-specific for antibiotic resistance. Target - An E. coli model hosting an essential mycobacterial metabolic pathway that could simplify drug screening. Infiltrate - A E. coli strain capable of entering infected macrophages and lysing mycobacteria. Sabotage - A non-lytic phage that spreads horizontally in a bacterial population and expresses an siRNA to knock down antibiotic resistance.
Target
test
Infiltrate
An effective TB therapy must reach mycobacteria inside lung macrophages. In this system, E. coli express lysteriolysin O (LLO) to enter the macrophage cytosol and Trehalose Dimycolate Hydrolase (TDMH) to degrade the pathogen's membrane.
+33 1 44 41 25 22/25
team2013@igem-paris.org 
